Figure 1. Diagram for detalied enrollement of patients. A total of 4,795 patients were enrolled for the cohort. After excluding 591 patients with either missing data or valvular disease or surgery, 4,204 patients were allocated in each group according to their CHA₂DS₂ VASc scores.